Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. (TERN) Stock Overview
Explore Terns Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.2B
P/E Ratio
-45.31
EPS (TTM)
$-1.02
ROE
-0.30%
TERN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Terns Pharmaceuticals, Inc. (TERN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.83.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -45.31 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.